References
- Ali Z, Yousaf N, Larkin J. Melanoma epidemiology, biology and prognosis. EJC Suppl. 2013;11(2):81–91. doi:https://doi.org/10.1016/j.ejcsup.2013.07.012
- Weitman ES, Zager JS. Regional therapies for locoregionally advanced and unresectable melanoma. Clin Exp Metastasis. 2018;35(5–6):495–502. doi:https://doi.org/10.1007/s10585-018-9890-1
- Swe T, Kim KB. Update on systemic therapy for advanced cutaneous melanoma and recent development of novel drugs. Clin Exp Metastasis. 2018;35(5–6):503–20. doi:https://doi.org/10.1007/s10585-018-9913-y
- Almeida FV, Douglass SM, Fane ME, Weeraratna AT. Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma. Pigment Cell Melanoma Res. 2019;32(2):237–47. doi:https://doi.org/10.1111/pcmr.12736
- Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;100(1–2):72–9. doi:https://doi.org/10.1016/j.jep.2005.05.011
- Wachtel-Galor S, Benzie IFF. Herbal medicine: Biomolecular and clinical aspects. 2nd ed. England: CRC Press/Taylor & Francis; 2011. p. 1–10. doi:https://doi.org/10.1186/1475-2891-9-3
- Greenwell M, Rahman PKSM. Medicinal plants: Their use in anticancer treatment. Int J Pharm Sci Res. 2015;6(10):4103–12. doi:https://doi.org/10.13040/IJPSR.0975-8232.6(10).4103-12
- Chinembiri TN, Du Plessis LH, Gerber M, Hamman JH, Du Plessis J. Review of natural compounds for potential skin cancer treatment. Molecules. 2014;19(8):11679–721. doi:https://doi.org/10.3390/molecules190811679
- Albuquerque KRS, Pacheco NM, Del Rosario Loyo Casao T, de Melo FCSA, Novaes RD, Gonçalves RV. Applicability of plant extracts in preclinical studies of melanoma: A systematic review. Mediators Inflamm. 2018;2018:6797924. doi:https://doi.org/10.1155/2018/6797924
- Danciu C, Soica C, Antal D, Alexa E, Pavel IZ, Ghiulai R, Ardelean F, Babuta RM, Popescu A, Dehelean CA, et al. Natural compounds in the chemoprevention of malignant melanoma. Anticancer Agents Med Chem. 2018;18(5):631–44. doi:https://doi.org/10.2174/1871520617666171121142522
- Davis PH. Flora of Turkey and the east Aegean Islands. Vol. 5. Edinburgh: Edinburgh at the University press; 1975.
- Ali-Shtayeh MS, Yaniv Z, Mahajna J. Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants. J Ethnopharmacol. 2000;73(1–2):221–32. doi:https://doi.org/10.1016/S0378-8741(00)00316-0
- Al-Dissi NM, Salhab AS, Al-Hajj HA. Effects of Inula viscosa leaf extracts on abortion and implantation in rats. J Ethnopharmacol. 2001;77(1):117–21. doi:https://doi.org/10.1016/S0378-8741(01)00261-6
- Zeggwagh NA, Ouahidi ML, Lemhadri A, Eddouks M. Study of hypoglycaemic and hypolipidemic effects of Inula viscosa L. aqueous extract in normal and diabetic rats. J Ethnopharmacol. 2006;108(2):223–7. doi:https://doi.org/10.1016/j.jep.2006.05.005
- Al-Qura’n S. Ethnopharmacological survey of wild medicinal plants in Showbak. Jordan. J Ethnopharmacol. 2009;123(1):45–50. doi:https://doi.org/10.1016/j.jep.2009.02.031
- Danino O, Gottlieb HE, Grossman S, Bergman M. Antioxidant activity of 1,3-dicaffeoylquinic acid isolated from Inula viscosa. Food Res Int. 2009;42(9):1273–80. doi:https://doi.org/10.1016/j.foodres.2009.03.023
- Seca AM, Grigore A, Pinto DC, Silva AM. The genus Inula and their metabolites: from ethnopharmacological to medicinal uses. J Ethnopharmacol. 2014;154(2):286–310. doi:https://doi.org/10.1016/j.jep.2014.04.010
- Das A, Shakya A, Ghosh SK, Singh UP, Bhat HR. A review of phytochemical and pharmacological studies of inula species. Curr Bioact Compd. 2020;16:557. doi:https://doi.org/10.2174/1573407215666190207093538
- Zhao Y-M, Zhang M-L, Shi Q-W, Kiyota H. Chemical constituents of plants from the genus Inula. Chem Biodivers. 2006;3(4):371–84. doi:https://doi.org/10.1002/cbdv.200690041
- Konishi T, Shimada Y, Nagao T, Okabe H, Konoshima T. Antiproliferative sesquiterpene lactones from the roots of Inula helenium. Biol Pharm Bull. 2002;25(10):1370–2. doi:https://doi.org/10.1248/bpb.25.1370
- Rozenblat S, Grossman S, Bergman M, Gottlieb H, Cohen Y, Dovrat S. Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochem Pharmacol. 2008;75(2):369–82. doi:https://doi.org/10.1016/j.bcp.2007.08.024
- Benbacer L, Merghoub N, El Btaouri H, Gmouh S, Attaleb M. Antiproliferative effect and induction of apoptosis by Inula viscosa L. and Retama monosperma L. extracts in human cervical cancer cells. Top Cervical Cancer Advocacy Prev. 2012;16:267–84. doi:https://doi.org/10.5772/30025
- Talib WH, Zarga MH, Mahasneh AM. Antiproliferative, antimicrobial and apoptosis inducing effects of compounds isolated from Inula viscosa. Molecules. 2012;17(3):3291–303. doi:https://doi.org/10.3390/molecules17033291
- Merghoub N, El Btaouri H, Benbacer L, Gmouh S, Trentesaux C, Brassart B, Terryn C, Attaleb M, Madoulet C, Benjouad A, et al. Inula viscosa extracts induces telomere shortening and apoptosis in cancer cells and overcome drug resistance. Nutr Cancer. 2016;68(1):131–43. doi:https://doi.org/10.1080/01635581.2016.1115105
- Bar-Shalom R, Bergman M, Grossman S, Azzam N, Sharvit L, et al. Inula viscosa extract inhibits growth of colorectal cancer cells in vitro and in vivo through ınduction of apoptosis. Front Oncol. 2019;10(9):227. doi:https://doi.org/10.3389/fonc.2019.00227
- Ozkan E, Pehlivan Karakas F, Birinci Yildirim AB, Tas I, Eker I, et al. Promising medicinal plant Inula viscosa L.: antiproliferative, antioxidant, antibacterial and phenolic profiles. Prog Nutr. 2019;21(3):652–61. doi:https://doi.org/10.23751/pn.v21i3.7186
- Virdis P, Migheli R, Galleri G, Fancello S, Cadoni MPL, Pintore G, Petretto GL, Marchesi I, Fiorentino FP, di Francesco A, et al. Antiproliferative and proapoptotic effects of Inula viscosa extract on Burkitt lymphoma cell line. Tumour Biol. 2020;42(2):1010428319901061. doi:https://doi.org/10.1177/1010428319901061
- Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017;18(1):529. doi:https://doi.org/10.1186/s12859-017-1934-z
- Read T, Lonne M, Sparks DS, David M, Wagels M, Schaider H, Soyer HP, Smithers BM. A systematic review and meta-analysis of locoregional treatments for in-transit melanoma. J Surg Oncol. 2019;119(7):887–96. doi:https://doi.org/10.1002/jso.25400
- Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75(3):311–35. doi:https://doi.org/10.1021/np200906s
- Talib WH, Mahasneh AM. Antiproliferative activity of plant extracts used against cancer in traditional medicine. Sci Pharm. 2010;78(1):33–45. doi:https://doi.org/10.3797/scipharm.0912-11
- Belayachi L, Aceves LC, Merghoub N, Bakri Y, Fernández de Mattos S, et al. Screening of North African medicinal plant extracts for cytotoxic activity against tumor cell lines. EJMP. 2013;3(3):310–32. /2013/3403 doi:https://doi.org/10.9734/EJMP
- Russo P, Malacarne D, Falugi C, Trombino S, O'Connor PM. RPR-115135, a farnesyltransferase inhibitor, increases 5-FU- cytotoxicity in ten human colon cancer cell lines: role of p53. Int J Cancer. 2002;100(3):266–75. doi:https://doi.org/10.1038/bjc.1998.617
- Park H, Park S-H, Jeong J-W, Yoon D, Han M, Lee D-S, Choi G, Yim M-J, Lee J, Kim D-H, et al. Induction of p53-independent apoptosis and G1 cell cycle arrest by fucoidan in HTC116 human colorectal carcinoma cells. Mar Drugs. 2017;15(6):154. doi:https://doi.org/10.3390/md15060154
- Krakhmal NV, Zavyalova MV, Denisov EV, Vtorushin SV, Perelmuter VM. Cancer invasion: Patterns and mechanisms. Acta Naturae. 2015;7(2):17–28. doi:https://doi.org/10.32607/20758251-2015-7-2-17-28
- Ruan J-S, Liu Y-P, Zhang L, Yan L-G, Fan F-T, Shen C-S, Wang A-Y, Zheng S-Z, Wang S-M, Lu Y, et al. Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition. Acta Pharmacol Sin. 2012;33(10):1325–31. doi:https://doi.org/10.1038/aps.2012.93
- Gao J, Yu H, Guo W, Kong Y, Gu l, Li Q, Yang S, Zhang Y, Wang Y. The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells. Cancer Cell Int. 2018;18(1):102. doi:https://doi.org/10.1186/s12935-018-0595-y
- Lee CM, Lee J, Nam MJ, Choi YS, Park SH. Tomentosin displays anti-carcinogenic effect in human osteosarcoma MG-63 cells via the induction of intracellular reactive oxygen species. Int IJMS. 2019;20(6):1508. doi:https://doi.org/10.3390/ijms20061508
- Haflidadóttir BS, Bergsteinsdóttir K, Praetorius C, Steingrímsson E. Steingrímsson E: miR-148 regulates Mitf in melanoma cells. PLoS One. 2010;5(7):e11574. doi:https://doi.org/10.1371/journal.pone.0011574
- Deng Y, Wang J, Huang M, Xu G, Wei W, Qin H. Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway. J Cell Mol Med. 2019;23(2):1415–26. doi:https://doi.org/10.1111/jcmm.14045
- Mueller DW, Bosserhoff AK. Role of miRNAs in the progression of malignant melanoma. Br J Cancer. 2009;101(4):551–6. doi:https://doi.org/10.1038/sj.bjc.6605204
- Liu S, Tetzlaff MT, Wang T, Yang R, Xie L, Zhang G, Krepler C, Xiao M, Beqiri M, Xu W, et al. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment. Pigment Cell Melanoma Res. 2015;28(4):431–41. doi:https://doi.org/10.1111/pcmr.12379
- Liu SM, Lu J, Lee HC, Chung FH, Ma N. miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2. Oncotarget. 2014;5(19):9444–59. doi:https://doi.org/10.18632/oncotarget.2452
- Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De Pittà C, et al. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. Embo J. 2011;30(10):1990–2007. doi:https://doi.org/10.1038/emboj.2011.102
- Xiao D, Barry S, Kmetz D, Egger M, Pan J, Rai SN, Qu J, McMasters KM, Hao H. Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment. Cancer Lett. 2016;376(2):318–27. doi:https://doi.org/10.1016/j.canlet.2016.03.050
- Xu W, Ji J, Xu Y, Liu Y, Shi L, Liu Y, Lu X, Zhao Y, Luo F, Wang B, et al. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells. Mol Carcinog. 2015;54(S1):E148–E161. doi:https://doi.org/10.1002/mc.22221
- Chen J, Feilotter HE, Paré GC, Zhang X, Pemberton JGW, Garady C, Lai D, Yang X, Tron VA. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol. 2010;176(5):2520–9. doi:https://doi.org/10.2353/ajpath.2010.091061
- Caramuta S, Egyházi S, Rodolfo M, Witten D, Hansson J, Larsson C, Lui W-O. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol. 2010;130(8):2062–70. doi:https://doi.org/10.1038/jid.2010.63
- Fattore L, Mancini R, Acunzo M, Romano G, Laganà A, Pisanu ME, Malpicci D, Madonna G, Mallardo D, Capone M, et al. miR-579-3p controls melanoma progression and resistance to target therapy. Proc Natl Acad Sci U S A. 2016;113(34):E5005–13. doi:https://doi.org/10.1073/pnas.1607753113
- Liu S, Tetzlaff MT, Cui R, Xu X. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1. Am J Pathol. 2012;181(5):1823–35. doi:https://doi.org/10.1016/j.ajpath.2012.07.009
- Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem. 2011;286(19):16606–14. doi:https://doi.org/10.1074/jbc.M111.227611
- Chen X, He D, Dong XD, Dong F, Wang J, Wang L, Tang J, Hu D-N, Yan D, Tu LLi, et al. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma. Invest Ophthalmol Vis Sci. 2013;54(3):2248–56. doi:https://doi.org/10.1167/iovs.12-10977
- Poenitzsch AM, Setaluri V, Spiegelman VS. microRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma. Arch Biochem Biophys. 2014;563:118–24. doi:https://doi.org/10.1016/j.abb.2014.07.012